N/A
Completed N=54
Monocentric Randomized Study, Assessing the Interests of the Determination of Vitamin D in Prison Population. (Vitamine D)
Male Prisoner
Source: ClinicalTrials.gov NCT02044133 ↗
Enrolled (actual)
54
Serious AEs
0.0%
Results posted
Sep 2025
Primary outcomePrimary: Dosage of Vitamin D — 28.2; 14.6 ng/mL — p=<0.001
Summary
The study will be proposed to man entering the prison of La Roche sur Yon. Participants will be randomized into two arms: one arm realize a dosage of vitamin D at the entrance and 6 months after the entry and the second arm will carry only a dosage six months after entry.
the purpose of the study is to determine the interest of dosage of vitamin D in biological assessment of entry into prison house.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Dosage of Vitamin D |
28.2; 14.6 | <0.001 sig |
Eligibility Criteria
Inclusion Criteria
- Incarcerated person
- Imprisoned in La Roche sur Yon
- Male
- Age > 18 year old
- Not opposed to participation in the study
Exclusion Criteria
- Intellectual deficit not to understand the study
- Taking osteoporosis treatment or any other affecting the metabolism of vitamin D
- Renal failure, liver failure
- Hypercalcemia
- Thyroid dysfunction, parathyroid diseases
- Duration of imprisonment less than the expected duration of the study.
- Incarcerated person who had received supplementation of vitamin D in the 6 months prior
Data sourced from ClinicalTrials.gov (NCT02044133). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.